Hudson Edge Investment Partners Inc. Purchases 230 Shares of Innospec Inc. (NASDAQ:IOSP)

Hudson Edge Investment Partners Inc. raised its position in Innospec Inc. (NASDAQ:IOSP) by 4.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,923 shares of the specialty chemicals company’s stock after acquiring an additional 230 shares during the period. Hudson Edge Investment Partners Inc.’s holdings in Innospec were worth $542,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Principal Financial Group Inc. lifted its holdings in shares of Innospec by 3.5% during the 4th quarter. Principal Financial Group Inc. now owns 129,448 shares of the specialty chemicals company’s stock valued at $14,247,000 after purchasing an additional 4,376 shares during the last quarter. State of New Jersey Common Pension Fund D raised its stake in Innospec by 3.3% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 17,989 shares of the specialty chemicals company’s stock valued at $1,980,000 after buying an additional 580 shares during the last quarter. New York State Teachers Retirement System boosted its holdings in Innospec by 1.4% in the fourth quarter. New York State Teachers Retirement System now owns 14,981 shares of the specialty chemicals company’s stock worth $1,649,000 after acquiring an additional 200 shares in the last quarter. Pacer Advisors Inc. purchased a new stake in shares of Innospec during the fourth quarter worth about $53,457,000. Finally, KBC Group NV increased its holdings in shares of Innospec by 82.3% during the fourth quarter. KBC Group NV now owns 1,236 shares of the specialty chemicals company’s stock valued at $136,000 after acquiring an additional 558 shares in the last quarter. 96.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of Innospec from a “strong-buy” rating to a “buy” rating in a research note on Saturday, January 11th.

Innospec Price Performance

Shares of IOSP opened at $103.46 on Friday. The company’s fifty day moving average price is $110.87 and its 200-day moving average price is $112.43. Innospec Inc. has a 1-year low of $99.49 and a 1-year high of $133.71. The firm has a market capitalization of $2.58 billion, a PE ratio of 72.86 and a beta of 1.09.

Innospec (NASDAQ:IOSP) last issued its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $1.41 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.05. The company had revenue of $466.80 million during the quarter, compared to analysts’ expectations of $447.43 million. Innospec had a return on equity of 12.27% and a net margin of 1.93%. As a group, research analysts anticipate that Innospec Inc. will post 6.18 EPS for the current fiscal year.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.